Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

$24.99

Common-Size Income Statement

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Merck & Co. Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Sales
Cost of sales
Gross profit
Selling, general and administrative
Research and development
Restructuring costs
Operating income
Interest income
Interest expense
Exchange losses
Income (loss) from investments in equity securities, net
Net periodic defined benefit plan credit other than service cost
Other, net
Other income (expense), net
Income from continuing operations before taxes
Taxes on income from continuing operations
Net income from continuing operations
Income from discontinued operations, net of taxes
Net income
Net (income) loss attributable to noncontrolling interests
Net income attributable to Merck & Co., Inc.

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Merck & Co. Inc. operating income as a percentage of sales increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Income from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Merck & Co. Inc. income from continuing operations before taxes as a percentage of sales decreased from 2021 to 2022 and from 2022 to 2023.
Net income attributable to Merck & Co., Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Merck & Co. Inc. net income attributable to Merck & Co., Inc. as a percentage of sales decreased from 2021 to 2022 and from 2022 to 2023.